tetano
Editor, Senior Moderator
J Bras Nefrol
. 2021 Mar 5;S0101-28002021005025303.
doi: 10.1590/2175-8239-JBN-2020-0208. Online ahead of print.
An analysis of chronic kidney disease as a prognostic factor in pediatric cases of COVID-19
[Article in English, Portuguese]
B?rbara Caroline Dias Faria[SUP] 1 [/SUP], Luiz Gustavo Guimar?es Sacramento[SUP] 1 [/SUP], Carolina Sant' Anna Filipin[SUP] 1 [/SUP], Aniel Feitosa da Cruz[SUP] 1 [/SUP], Sarah Naomi Nagata[SUP] 1 [/SUP], Ana Cristina Sim?es E Silva[SUP] 2 [/SUP]
Affiliations
Abstract
Advanced age is a risk factor for severe infection by acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Children, however, often present with milder manifestations of Coronavirus Disease 2019 (COVID-19). Associations have been found between COVID-19 and multisystem inflammatory syndrome in children (MIS-C). Patients with the latter condition present more severe involvement. Adults with comorbidities such as chronic kidney disease (CKD) are more severely affected. This narrative review aimed to look into whether CKD contributed to more severe involvement in pediatric patients with COVID-19. The studies included in this review did not report severe cases or deaths, and indicated that pediatric patients with CKD and previously healthy children recovered quickly from infection. However, some patients with MIS-C required hospitalization in intensive care units and a few died, although it was not possible to correlate MIS-C and CKD. Conversely, adults with CKD reportedly had increased risk of severe infection by SARS-CoV-2 and higher death rates. The discrepancies seen between age groups may be due to immune system and renin-angiotensin system differences, with more pronounced expression of ACE2 in children. Immunosuppressant therapy has not been related with positive or negative effects in individuals with COVID-19, although current recommendations establish decreases in the dosage of some medications. To sum up with, CKD was not associated with more severe involvement in children diagnosed with COVID-19. Studies enrolling larger populations are still required.
. 2021 Mar 5;S0101-28002021005025303.
doi: 10.1590/2175-8239-JBN-2020-0208. Online ahead of print.
An analysis of chronic kidney disease as a prognostic factor in pediatric cases of COVID-19
[Article in English, Portuguese]
B?rbara Caroline Dias Faria[SUP] 1 [/SUP], Luiz Gustavo Guimar?es Sacramento[SUP] 1 [/SUP], Carolina Sant' Anna Filipin[SUP] 1 [/SUP], Aniel Feitosa da Cruz[SUP] 1 [/SUP], Sarah Naomi Nagata[SUP] 1 [/SUP], Ana Cristina Sim?es E Silva[SUP] 2 [/SUP]
Affiliations
- PMID: 33704348
- DOI: 10.1590/2175-8239-JBN-2020-0208
Abstract
Advanced age is a risk factor for severe infection by acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Children, however, often present with milder manifestations of Coronavirus Disease 2019 (COVID-19). Associations have been found between COVID-19 and multisystem inflammatory syndrome in children (MIS-C). Patients with the latter condition present more severe involvement. Adults with comorbidities such as chronic kidney disease (CKD) are more severely affected. This narrative review aimed to look into whether CKD contributed to more severe involvement in pediatric patients with COVID-19. The studies included in this review did not report severe cases or deaths, and indicated that pediatric patients with CKD and previously healthy children recovered quickly from infection. However, some patients with MIS-C required hospitalization in intensive care units and a few died, although it was not possible to correlate MIS-C and CKD. Conversely, adults with CKD reportedly had increased risk of severe infection by SARS-CoV-2 and higher death rates. The discrepancies seen between age groups may be due to immune system and renin-angiotensin system differences, with more pronounced expression of ACE2 in children. Immunosuppressant therapy has not been related with positive or negative effects in individuals with COVID-19, although current recommendations establish decreases in the dosage of some medications. To sum up with, CKD was not associated with more severe involvement in children diagnosed with COVID-19. Studies enrolling larger populations are still required.